Det aktive stof i Arixtra, fondaparinuxnatrium, blokerer et af de stoffer, faktor Xa, der medvirker ved blodets størkning.
The active ingredient in Arixtra, fondaparinux sodium, stops one of the substances (factors) that are involved in the clotting of blood, Factor Xa.